Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Colorectal Neoplasms

Free Subscription 04.05.2025 1 Ann Oncol 1 Ann Surg Oncol 2 Anticancer Res 3 BMC Cancer 4 BMC Gastroenterol 2 Br J Cancer 1 Br J Surg 2 Cancer 1 Cancer Lett 1 Cancer Res 4 Clin Cancer Res 1 Dis Colon Rectum 4 Eur J Cancer 4 Gastrointest Endosc 1 Int J Cancer 1 Int J Colorectal Dis 1 J Clin Oncol 8 J Surg Oncol 1 Oncol Rep 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Oncol

1. WILLIAMS H, Fokas E, Diefenhardt M, Lee C, et al
   Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials.
   Ann Oncol. 2025;36:543-547.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. TAQI K, Mack L, Bouchard-Fortier A
   ASO Authors Reflections: Beyond the Boundaries of Colorectal Cancer Peritoneal and Liver Metastases: Insights from a Systematic Review.
   Ann Surg Oncol. 2025 Apr 29. doi: 10.1245/s10434-025-17395.
   PubMed        
   
   

   
   Anticancer Res

3. IZUTANI Y, Ogino T, Fujii M, Sekido Y, et al
   Appendectomy Mitigates Ulcerative Colitis Activity and Delays Colorectal Cancer Onset: A Retrospective Cohort Study.
   Anticancer Res. 2025;45:2205-2214.
   PubMed         Abstract available
   
   
4. HWANG HH, Yoo JS, Je JH, Lee HC, et al
   SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway.
   Anticancer Res. 2025;45:1965-1980.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. LI W, Liu B, Xiang X, Zhang Q, et al
   Lymphovascular invasion affects prognosis of colorectal cancer liver metastasis underwent primary resection: a propensity score matching analysis.
   BMC Cancer. 2025;25:793.
   PubMed         Abstract available
   
   
6. WISMAYER R, Matthews R, Whalley C, Kiwanuka J, et al
   The role of MLH1, MSH2 and MSH6 in the development of colorectal cancer in Uganda.
   BMC Cancer. 2025;25:792.
   PubMed         Abstract available
   
   
7. CHIGVINADZE N, Pantsulaia I, Lejava T, Aladashvili A, et al
   Suppressor protein plasma levels and inflammatory indices in colorectal cancer patients.
   BMC Cancer. 2025;25:774.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

8. ZENG F, Chen S, Zhu X, Chen J, et al
   Analysis of the effect of fecal SDC2, ADHFE1 and PPP2R5C gene methylation test for screening colorectal cancer in the Otog Front Banner.
   BMC Gastroenterol. 2025;25:324.
   PubMed         Abstract available
   
   
9. YANG R, Liu W, Cai S, Feng X, et al
   Evaluation of the efficacy of probiotics in the chemoradiotherapy of colorectal cancer: a meta-analysis of Randomized Controlled Trials.
   BMC Gastroenterol. 2025;25:312.
   PubMed         Abstract available
   
   
10. HUANG L, Zhao K, Lu H, He W, et al
    Serum cholinesterase combined with platelet-to-hemoglobin ratio for predicting survival prognosis in stage I-III colorectal cancer patients undergoing radical surgery: a retrospective cohort study.
    BMC Gastroenterol. 2025;25:319.
    PubMed         Abstract available
    
    
11. LUO J, Zhu P, Zhou S
    Association between the red blood cell distribution width-to-albumin ratio and risk of colorectal and gastric cancers: a cross-sectional study using NHANES 2005-2018.
    BMC Gastroenterol. 2025;25:316.
    PubMed         Abstract available
    
    

    
    Br J Cancer

12. YUAN F, Jia G, Wen W, Xu S, et al
    Blood metabolic biomarkers and colorectal cancer risk: results from large prospective cohort and Mendelian randomisation analyses.
    Br J Cancer. 2025 Apr 30. doi: 10.1038/s41416-025-02997.
    PubMed         Abstract available
    
    
13. REITSAM NG, Markl B
    Stroma AReactive Invasion Front Areas (SARIFA) and the tumour immune microenvironment in colorectal cancer.
    Br J Cancer. 2025 Apr 26. doi: 10.1038/s41416-025-03034.
    PubMed        
    
    

    
    Br J Surg

14. HAMM JJM, van den Berg R, Andrinopoulou ER, Zwanenburg ES, et al
    Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis.
    Br J Surg. 2025;112:znaf076.
    PubMed         Abstract available
    
    

    
    Cancer

15. LEE S, Ma C, Caan BJ, Binder AM, et al
    Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancer.
    Cancer. 2025;131:e35865.
    PubMed         Abstract available
    
    
16. NIERENGARTEN MB
    Calcium may help to protect against colorectal cancer.
    Cancer. 2025;131:e35827.
    PubMed        
    
    

    
    Cancer Lett

17. DANEK V, Tureckova J, Huebner K, Erlenbach-Wuensch K, et al
    CUL4A exhibits tumor-suppressing role via regulation of HUWE1-mediated SMAD3 intracellular shuttling.
    Cancer Lett. 2025;621:217663.
    PubMed         Abstract available
    
    

    
    Cancer Res

18. BUCKENMEYER MJ, Brooks EA, Taylor MS, Orenuga IK, et al
    A 3D Self-Assembly Platform Integrating Decellularized Matrix Recapitulates In Vivo Tumor Phenotypes and Heterogeneity.
    Cancer Res. 2025;85:1577-1595.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

19. APPLEYARD JW, Williams CJM, Manca P, Pietrantonio F, et al
    Targeting the MAP kinase pathway in colorectal cancer: A journey in personalized medicine.
    Clin Cancer Res. 2025 May 1. doi: 10.1158/1078-0432.CCR-25-0107.
    PubMed         Abstract available
    
    
20. ONG JC, Zhao JJ, Liu Y, Srivastava S, et al
    Spatial heterogeneity, stromal phenotypes, and therapeutic vulnerabilities in colorectal cancer peritoneal metastasis.
    Clin Cancer Res. 2025 Apr 29. doi: 10.1158/1078-0432.CCR-24-3780.
    PubMed         Abstract available
    
    
21. WANKHEDE D, Halama N, Kloor M, Edelmann D, et al
    Prognostic Value of CD8+ T Cells at the Invasive Margin Is Comparable to the Immune Score in Nonmetastatic Colorectal Cancer: A Prospective Multicentric Cohort Study.
    Clin Cancer Res. 2025;31:1711-1718.
    PubMed         Abstract available
    
    
22. MORRIS VK, Liu S, Lin K, Zhu H, et al
    Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Clin Cancer Res. 2025;31:1657-1666.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

23. MYERS S, Davis ES, Sacks OA, Franks JA, et al
    Disparities In Uptake of the 2021 United States Preventive Services Task Force Colorectal Cancer Screening Recommendations Among Adults Aged 45-49.
    Dis Colon Rectum. 2025 Apr 29. doi: 10.1097/DCR.0000000000003789.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

24. PIZZAMIGLIO M, Soulabaille A, Lahlou W, Pilla L, et al
    Advances and challenges in targeted therapies for HER2-amplified colorectal cancer.
    Eur J Cancer. 2025;222:115471.
    PubMed         Abstract available
    
    
25. MORETTO R, Rossini D, Polito MG, Antoniotti C, et al
    The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies.
    Eur J Cancer. 2025;222:115470.
    PubMed         Abstract available
    
    
26. NORONHA MM, Costa Almeida LF, Cappellaro AP, Silva LFLD, et al
    Neoadjuvant chemotherapy for colon cancer: A systematic review and meta-analysis of randomized controlled trials.
    Eur J Cancer. 2025;222:115476.
    PubMed         Abstract available
    
    
27. JORGENSEN SF, Njor SH, Nevala A, Palsson B, et al
    Nordic colorectal cancer screening programmes: A comparison of organization, operation, and quality indicators.
    Eur J Cancer. 2025;222:115444.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

28. HUANG ES, Huang Q, Kenkare P, Mudiganti S, et al
    Prevalence of "one and done" phenomenon in adenoma detection within a large community-based healthcare system.
    Gastrointest Endosc. 2025;101:1038-1050.
    PubMed         Abstract available
    
    
29. WU Y, Zhang Z
    Enhancing colorectal cancer screening models through updated parameters and sensitivity analyses.
    Gastrointest Endosc. 2025;101:1094-1095.
    PubMed        
    
    
30. HOTTA N, Ohmiya N, Hiraga H, Nakaji K, et al
    Nationwide multicenter prospective study on the usefulness, safety, and acceptability of colon capsule endoscopy in Japan.
    Gastrointest Endosc. 2025;101:1051-1063.
    PubMed         Abstract available
    
    
31. HIRAI R, Kinugasa H, Ishiguro M, Toyosawa J, et al
    Short- and longer-term learning effects from virtual scale endoscopy videos: a useful tool for colorectal lesion size estimation (with videos).
    Gastrointest Endosc. 2025;101:1030-1037.
    PubMed         Abstract available
    
    

    
    Int J Cancer

32. HOANG T, Choi MK, Oh JH, Kim J, et al
    Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: A systematic review and network meta-analysis.
    Int J Cancer. 2025 Apr 28. doi: 10.1002/ijc.35442.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

33. ZHANG G, Zhang Z, Zhou Y
    Associations between FOXO1 expression in tissue, the pathological characteristics of colorectal cancer, and patient survival.
    Int J Colorectal Dis. 2025;40:105.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

34. VEENSTRA CM, Abrahamse P, Hamilton AS, Ward KC, et al
    Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2.
    J Clin Oncol. 2025;43:1587-1596.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

35. CONNOR CHICK R, Ruff SM, Monasterio J, Neilson T, et al
    Implementation of Hepatic Artery Infusion Pump Therapy: Real-World Single-Center Experience.
    J Surg Oncol. 2025;131:212-219.
    PubMed         Abstract available
    
    
36. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    Factors Associated With Prolonged Operative Times in Laparoscopic Right Hemicolectomy and Its Association With Short-Term Outcomes.
    J Surg Oncol. 2025;131:143-150.
    PubMed         Abstract available
    
    
37. NASIM BW, Murphy S, Yracheta J, Clark AL, et al
    Barriers to Offering Organ Preservation for Rectal Cancer in a Predominantly Hispanic Safety Net Hospital.
    J Surg Oncol. 2025;131:183-188.
    PubMed         Abstract available
    
    
38. KARIM A, Troester A, Mott SL, Arsoniadis E, et al
    A Population-Level Validation of the New 9th Edition of the American Joint Commission on Cancer Staging System for Anal Squamous Cell Carcinoma.
    J Surg Oncol. 2025;131:481-488.
    PubMed         Abstract available
    
    
39. ONG WL, Morarasu S, Lunca S, Pruna RM, et al
    Impact of Clostridium difficile Infection Versus Colonization on Postoperative Outcomes After Oncological Colorectal Surgery: An Observational Single-Center Study With Propensity Score Analysis.
    J Surg Oncol. 2025;131:489-497.
    PubMed         Abstract available
    
    
40. BAUER PS, Gamboa AC, Otegbeye EE, Chapman WC Jr, et al
    Short-Course TNT Improves Rectal Tumor Downstaging in a Retrospective Study of the US Rectal Cancer Consortium.
    J Surg Oncol. 2025;131:498-506.
    PubMed         Abstract available
    
    
41. MAHURON KM, Hernandez MC, Wong P, Fan D, et al
    Liver Resection With Extrahepatic Disease: A Population-Based Analysis of Thoughtful Selection.
    J Surg Oncol. 2025;131:443-449.
    PubMed         Abstract available
    
    
42. ARAUJO ROC, Valadao M, Silva JADDCE, Lintomen L, et al
    Implementation of a Screening Program for High-Grade Anal Dysplasia in High-Risk Patients in a Tertiary Cancer Center.
    J Surg Oncol. 2025;131:151-159.
    PubMed         Abstract available
    
    

    
    Oncol Rep

43. LI C, Cheng X, Jiang Y
    Deuterium-depleted water inhibits the malignant progression of colorectal cancer cells by modulating oxidative stress.
    Oncol Rep. 2025;53:70.
    PubMed         Abstract available
    
    

    
    PLoS One

44. MARTINEZ-RIOS J, Lopez-Pacheco CP, Garcia-Zepeda EA, Soldevila G, et al
    CCR9 shapes the immune microenvironment of colorectal cancer modulating the balance between intratumoral CD8+ T cell and FoxP3+ Helios+ Treg subpopulations.
    PLoS One. 2025;20:e0321930.
    PubMed         Abstract available
    
    
45. HAI MINH N, Quy TQ, Tam ND, Tuan TM, et al
    A practical approach for colorectal cancer diagnosis based on machine learning.
    PLoS One. 2025;20:e0321009.
    PubMed         Abstract available
    
    
46. MCCREADY TM, Cohen EM, Laynor G, Chebli P, et al
    Addressing the immigrant screening gap: A protocol for a systematic review on interventions to enhance colorectal cancer screening among immigrants in the United States.
    PLoS One. 2025;20:e0322038.
    PubMed         Abstract available
    
    
47. SANCHEZ-SANTIESTEBAN D, Patino-Benavidez AF, Buitrago G
    Socioeconomic inequalities of 3-year survival in formal employees with colorectal cancer between 2012 and 2019 in Colombia.
    PLoS One. 2025;20:e0316061.
    PubMed         Abstract available
    
    
48. KANG D, Li J, Li Y, Xu J, et al
    Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II/III colorectal cancer: A retrospective study and meta-analysis.
    PLoS One. 2025;20:e0320783.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.